Heart Team
The 2016 European Society of Cardiology guidelines for the management of AF recommends integrated care in the treatment of AF and follows a patient-centered, multidisciplinary team approach. 3 This multidisciplinary collaboration between at least a cardiothoracic surgeon having AF knowledge and experience, an EP experienced in the catheterbased management of AF, as well as a dedicated nurse involved in patient care should be structured in a heart team with weekly meetings. Noninvasive cardiologists, interventional cardiologists, neurologists (AF-related ischemic or hemorrhagic stroke), and medical providers from other disciplines can be asked to join if needed. This workflow is not only there to improve patient outcomes by optimizing the treatment and restoring sinus rhythm, but most importantly to limit the potential risks associated with the choice of procedure, thereby minimizing complication rates. In current practice, most patients with paroxysmal atrial fibrillation (PAF) and persistent AF have had at least 1 unsuccessful catheter-based ablation before referral to the team and thus referred by the EP. An EP wire survey by Pison et al. in Europe showed a wide variation in indications for stand-alone surgical AF ablation. The most important was failed catheter ablation. The other indications were (in descending order of importance) primary intervention for longstanding persistent AF, patient preference, thromboembolic advantage with LAA exclusion, shorter waiting list, failed transseptal technique, and study protocol.
Patient Selection
Which patients to select is relatively easy to define. All patients with a history of symptomatic AF, regardless of classification (paroxysmal, persistent, or longstanding persistent), refractory to or intolerant to at least one class I (flecainide/ propafenone) or III (sotalol/amiodarone) antiarrhythmic drug could be candidates. The choice to perform a hybrid ablation should, therefore, depend upon a patient's needs in terms of relieve or improvement of symptoms (according to the Modified European Heart Rhythm Association symptom scale) and the risk for thromboembolic events. As mentioned earlier, there is a tendency to refer more challenging cases. We should be aware that not all patients are good candidates because of lower success rates or because they have a higher risk for peri-and postoperative complications. Possible exclusion criteria could be presence of LAA thrombus, left ventricular ejection fraction <35%, a history of thoracotomy or cardiac surgery, body mass index >40 kg/m 2 , significant lung dysfunction or chronic obstructive pulmonary disease, and a left atrial size ≥70 mL/m² on transoesophageal echocardiogram. For this patient group a minimally invasive Cox maze procedure could be discussed.
To improve patient selection and to ensure high-quality outcomes, there are different types of diagnostic tests required. These should include standard preoperative exams performed prior to all cardiac surgeries (electrocardiogram, blood tests, chest X-ray, echo heart). Furthermore, a computed tomography (CT)-heart should be performed to understand the anatomy of the PVs and the atria (the CT will also be used to merge with the EP's mapping system), to evaluate coronary artery disease (CAD), to evaluate the thickness of epicardial fat at the levels of the atria, and to exclude a thrombus in the LAA. Depending on the diagnosis of CAD, a coronarography could be added. For those patients planned for a thoracoscopic approach a pulmonary function test is also needed.
The Approach
It is important for surgeons to become familiar with the anatomical basis of minimally invasive epicardial ablation of AF and the different possibilities of access. 5 Surgical access can vary from a monolateral or bilateral thoracoscopy (or thoracotomy) to a subxyphoid access. The limitation of the right-sided thoracoscopic and the subxyphoid approach is the inability to exclude the LAA. The choice will depend upon the patient's AF, risk factors, lesion set, ablation tools, need for LAA occlusion (LAAO), and surgeons' experience. Looking at the literature the outcomes and complication rates seem similar for the different approaches. The timing of the staging of the hybrid procedure can also vary. In a one-stage approach, surgeons and EPs treat the patient the same day. The sequential approach consists of the 2 procedures performed on different days, but during the same hospitalization. Finally, a third option is a 2-staged approach where the second procedure is performed later, but within 6 months of the initial ablation. This should be clearly discussed in the heart team before starting a hybrid program. It is clear that decision-making cannot only depend upon the view of the surgeon or the EP, and the strength of the team is bringing together the best of 2 worlds.
After the first report on the outcomes of a hybrid thoracoscopic surgical and transvenous catheter ablation procedure for AF by the group in Maastricht, one could indeed assume that a single-step hybrid ablation of AF is technically more difficult. In an editorial by Dr Hugh Calkins, the most important limitation was what he called a logistical nightmare: the necessity to have experts in both catheter ablation and surgical ablation available in the same hospital, on the same day. 6 For centers confronted with this problem, a staged hybrid approach is a solution, since published outcomes and complication rates are similar for both approaches. The set-up of the hybrid room is shown in Figs. 1 and 2. 
The Ablation Tools and Lesion Set
In general, patients referred for surgical ablation of AF are challenging because the other treatment options (medications, cardioversions, and endocardial ablation) have failed or are no longer considered. As a consequence, the triggers and substrate of the arrhythmia are typically more difficult to treat and usually accompanied by an enlarged left atrium and fibrosis. Therefore, when using a limited lesion set in these patients, a less favorable outcome could be expected. This could be in favor of a hybrid procedure, since all lesion sets starting from PVI to a full Cox maze are possible on the beating heart using this technique.
There is an extensive choice of ablation tools using monopolar or bipolar energy, in monodirectional or bidirectional devices. The epicardial lesion set always consists of left atrial lesions, but can be complemented with a right atrial ablation. Pulmonary vein isolation, roof line (connecting line between the superior PVs), inferior line (connecting line between the inferior PVs), a box lesion, connecting line to the LAA, and ablation of ganglionated plexi are mostly the standard lesions. In the subxyphoid convergent procedure, using a pericardioscopic approach, the posterior left atrial wall is ablated using a unipolar radiofrequency device. If there is a need for LAAO, this has to be performed either by a left thoracoscopy or an endocardial transvenous closing device.
The endocardial control and, if needed, add-on ablation performed by the EP consist of a left-sided and, if needed, right-sided approach. This approach, using mapping technology, is most effective in targeting specific areas of arrhythmogenic interest and can complete nontransmural epicardial lesions. Ablation will be performed if there is necessity for completion of lines, left and right isthmus ablation, ablation of atrial tachycardia, and substrate ablation.
The Left Atrial Appendage
An important difference between a hybrid and an endocardial ablation is the treatment of the LAA. Most patients undergoing a hybrid AF procedure do have their LAA addressed, while few undergoing an EP ablation will. The role of the LAA in arrhythmogenesis has been reported; it is considered to be a common site of non-PV sources in initiating or maintaining AF. Surgical LAAO, thus, potentially decreases foci and substrate by electrical isolation. It will also prevent the formation of thrombi inside the LAA, thereby potentially reducing the stroke risk. But several studies have raised significant concerns regarding classical surgical techniques for LAA closure. The Left Atrial Appendage Occlusion Study of 77 patients undergoing concurrent CABG showed that occlusion of the LAA by suture or stapling without amputation was incomplete in 44% of the cases. 7 Due to the frailty of the LAA and bleeding risks, it has to be treated with our uttermost respect. In a recent paper by Wehbe et al., 2 fatal bleeding complications were described after LAA exclusion. 8 An atraumatic exclusion technique with electrical isolation should be preferred. 
The Complications
EPs and cardiac surgeons performing AF ablation procedures must be familiar with the complications in both fields, and the potential risks and benefits should be weighed for every individual patient. Major and minor complications should perhaps be defined as lasting and temporary (nonlasting) complications, to better understand the importance when comparing results. In general, complications are higher among hybrid studies compared to catheter-only ablation and to a minimally invasive Cox maze. They include cardiac tamponade, reoperation for bleeding, bleeding requiring transfusion, conversion to sternotomy, phrenic nerve injury, hospital mortality, pacemaker implantation, and pneumothorax. This higher complication rate can be explained. Many papers on hybrid procedures are initial experiences with centers in their learning curve and with insufficient training. It is very important to understand the necessity of education and training of both teams. In general, the EP will already have a successful program of endocardial procedures. In most centers the surgeon will not have the minimally invasive skills needed. These are not to be underestimated and require an expertise that is different from open chest surgery. Detailed knowledge about the anatomy of the left atrium and its adjacent structures is crucial for safety. The anatomical structures relevant to the pathogenesis and the epicardial treatment of AF include the PVs, the pericardial space, the pericardial sinuses, the phrenic nerve, the left atrium, the retro-atrial and caval ganglionated plexuses, the ligament of Marshall, the caval veins, and the LAA. To approach these structures with a thoracoscopic or subxyhoideal camera-based technique, the eye has to be taught since the 2-dimensional visualization is completely different compared to a standard open anteroposterior technique. Furthermore, the choice and precise manipulation of the ablation tools, specifically designed for a minimally invasive access, are a potential concern. Bipolar radiofrequency clamps are associated with reliable transmural lesions, but necessitate a more complex bilateral approach and a nonvisualized blunt dissection of the pericardial reflection of the oblique and transverse sinuses. Nonclamping ablation devices can be technically less challenging but have shown less efficacy for the creation of transmural lesions. Not properly controlling the dissection of tissue and the placement of catheters can cause life-threatening complications. Therefore, surgeons who are new to minimally invasive procedures in AF should be proctored by an experienced colleague. Although the effectiveness of a training program is unclear, it is generally agreed upon that a minimum 5 up to 10 cases are needed before performing these ablations alone. Also, the impact of surgeon experience on complication rates and long-term sinus rhythm has not been thoroughly studied. One could assume that this should be the same as needed for other cardiac surgery procedures, and that, therefore, a minimum case load per month is needed.
Outcomes and Methods of Follow-up
Claudia van der Heijden et al. conducted a systematic literature review and meta-analysis of hybrid versus catheter ablation in patients with persistent or longstanding persistent AF. 10 Hybrid ablation resulted in higher freedom of atrial arrhythmias in patients with persistent and longstanding-persistent AF than catheter ablation (70.7%, 49.9%, P < .001). Although hybrid ablation had a slightly higher complication rate than catheter ablation, overall morbidity and mortality were low. The authors concluded that hybrid ablation is more effective than catheter ablation in maintaining the sinus rhythm in patients with persistent or longstanding persistent AF. However, the limitations of the study showed that data directly comparing both techniques are lacking and small, heterogenic, single-arm studies in a random-effect model prevent definite conclusions from being drawn.
According to guidelines the follow-up after ablation should be structured to ensure continued optimal management. Early recurrences of AF after AF ablation have been defined as any recurrence of AF, AT, or atrial flutter >30 seconds during the first 3 months of follow-up (blanking period). Late recurrence has been defined as any recurrence between 3 and 12 months after AF. Available methods for arrhythmia monitoring, noncontinuous or continuous, will differ between centers. But significant challenges are present due to the patient's perception of absence of arrhythmia, therefore not feeling a need for long-term monitoring and added cost. Most published papers on hybrid procedures report at least a mean follow-up duration of 12 months, and the monitoring during follow-up is often a 7-day Holter.
Finally, when to add a repeat endocardial procedure for recurrences? In this patient population the most frequent arrhythmias seen are new left atrial flutters and less often AF. As with the indication for a hybrid procedure, the choice to perform a new endocardial ablation should depend upon the patient's needs and the consequences of arrhythmia detection. In a study by Velagic et al., the authors concluded that a hybrid AF ablation results in durable lesions and high rates of chronic PVI even after long-term follow-up and that in most of the repeat procedures after the hybrid approach the arrhythmia could be successfully treated by catheter ablation. 11 Therefore, the same decision making should be used as with a recurrence after a percutaneous endocardial ablation.
Conclusions
In a hybrid surgical ablation, the approach and precise lesion set in a given patient can be tailored on the basis of the pathology. It is a safe and effective strategy for the treatment of AF in centers with an AF heart team and experience. Knowledge of patient selection and appropriate technical competence is mandatory to achieve good outcomes and to prevent, recognize, and manage complications. Although health care funding remains limited in many countries, the increased budget impact of a hybrid program could well be accepted if proven that this increases safety and efficacy. Therefore, larger randomized controlled trials (RCTs) directly comparing both techniques are needed. Two ongoing RCTs comparing a hybrid simultaneous approach (HART-CAP AF) and a hybrid staged approach (CEASE-AF) with catheter ablation in patients with persistent and long-standing persistent AF will most probably provide important data on improvement in quality of life, decreased stroke risk by reduction of thromboembolic events, decreased heart failure risk, perhaps improved survival, and complication rates.
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